PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Chart, page-2167

  1. 742 Posts.
    lightbulb Created with Sketch. 206
    Although the outstanding issue appears fairly innocuous, the fact PAR weren’t able to address it in the 30 days seems to have cost plenty. No hurry for anyone to invest, short term investors missed the calculated risk of expecting a go ahead so will sell, some long term holders a little worn out and a broker downgrade all helping any shorter go harder for the near term. All compounding the current state. There will be a short term bottom (probably see it on a chart) and hopefully within the next two months it turns the corner. Management doesn’t escape some criticism due to missing momentum created by getting it right the first time. Good luck to them getting what is a rather large process done successfully. Tks for those regulars posting some very informative stuff and GLTA It’s usually a marathon in this sector.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $80.45M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $111.8K 474.3K

Buyers (Bids)

No. Vol. Price($)
2 51794 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 34852 7
View Market Depth
Last trade - 12.59pm 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.